BNO 5.26% 20.0¢ bionomics limited

Ann: Commencement of BNC210 Phase 2 Agitation Trial, page-30

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 590 Posts.
    lightbulb Created with Sketch. 4
    i think mama rathjen said in one of her recent talks, the one that windshift posted the video link for, that becuase GAD has approved treatments and 210 is a brand new method of action the fda would be quite strict around approval.
    trialing similar dieseases where there is no approved treatment they felt would be easier when meeting with the fda. which they will have to do prior to any phase 3.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.